Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
3.6
-12.48%
40%
—
-100.00%
60%
—
5 Years
Score3.6
Net Growth-12.48%
Net Trend40%
Net Income Consistency—
Rev Growth-100.00%
Rev Trend60%
Revenue Consistency—
Century Therapeutics Inc fundamental performance
Between 2021 and 2025, revenue grew from $ 1M to $ 109M and net income went from -$ 95M to -$ 9M. Revenue increased in 60% of the years measured; net income in 40%.
Century Therapeutics Inc currently holds a 5-year HDB Score of 3.6 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.96 | — |
1 Year2025-08-12 | $ 0.52 | 278.38% |
5 Years2021-08-12 | $ 31.40 | -93.76% |
All Time2021-06-18 | $ 22.83 | -91.41% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-06-18 |
|---|---|---|---|---|
| Price | $ 1.96 | $ 0.52 | $ 31.40 | $ 22.83 |
| Return | — | 278.38% | -93.76% | -91.41% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 107M | $ 134M |
| 2025 | $ 109M | -$ 9M | $ 117M |
| 2024 | $ 6M | -$ 126M | $ 189M |
| 2023 | $ 2M | -$ 136M | $ 172M |
| 2022 | $ 5M | -$ 130M | $ 315M |
| IPO2021 | $ 1M | -$ 95M | $ 222M |
Explore beyond IPSC
You're looking at Century Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
